Ftse Mib
34.186,18
0,00%
DAX
19.909,14
0,00%
S&P 500
5.881,63
-0,43%
NASDAQ
19.310,79
-0,90%
Bitcoin
95.729,32
1,42%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AC Immune SA (ACIU) AC Immune SA (ACIU) Notizie

ACIU

AC Immune (ACIU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACIU
DataOraFonteTitoloSimboloCompagnia
18/12/202423:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
13/12/202423:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACIUAC Immune SA
10/12/202413:00GlobeNewswire Inc.AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndromeNASDAQ:ACIUAC Immune SA
14/11/202413:00GlobeNewswire Inc.AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseNASDAQ:ACIUAC Immune SA
13/11/202413:00GlobeNewswire Inc.AC Immune to Present at the Jefferies 2024 London Healthcare ConferenceNASDAQ:ACIUAC Immune SA
05/11/202413:00GlobeNewswire Inc.AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:ACIUAC Immune SA
27/09/202422:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
06/08/202422:50Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACIUAC Immune SA
01/08/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACIUAC Immune SA
26/07/202422:53Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:ACIUAC Immune SA
09/02/202422:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACIUAC Immune SA
03/01/202414:10GlobeNewswire Inc.AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseasesNASDAQ:ACIUAC Immune SA
27/06/202319:30AllPennyStocks.comBiotech Pops On FDA Fast Track DesignationNASDAQ:ACIUAC Immune SA
27/06/202314:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ACIUAC Immune SA
27/06/202314:11Dow Jones NewsAC Immunity Shares Jump 18% After Fast-Track Designation on Alzheimer's TreatmentNASDAQ:ACIUAC Immune SA
16/03/202312:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ACIUAC Immune SA
10/02/202322:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACIUAC Immune SA
01/12/202214:45TipRanksH.C. Wainwright Keeps Their Buy Rating on AC Immune SA (ACIU)NASDAQ:ACIUAC Immune SA
02/11/202205:45TipRanksSVB Securities Sticks to Its Buy Rating for AC Immune SA (ACIU)NASDAQ:ACIUAC Immune SA
31/10/202211:15TipRanksAC Immune SA (ACIU) Receives a Buy from H.C. WainwrightNASDAQ:ACIUAC Immune SA
29/08/202205:15TipRanksSVB Securities Keeps Their Buy Rating on AC Immune SA (ACIU)NASDAQ:ACIUAC Immune SA
11/07/202214:40TipRanksSVB Securities Thinks AC Immune SA’s Stock is Going to RecoverNASDAQ:ACIUAC Immune SA
19/06/202209:05TipRanksH.C. Wainwright Sticks to Their Buy Rating for AC Immune SA (ACIU)NASDAQ:ACIUAC Immune SA
16/06/202212:57Dow Jones NewsAC Immune Shares Fall Premarket on Alzheimer's Study MissNASDAQ:ACIUAC Immune SA
29/04/202212:26TipRanksH.C. Wainwright Thinks AC Immune SA’s Stock is Going to RecoverNASDAQ:ACIUAC Immune SA
21/12/202108:11TipRanksLeerink Partners Sticks to Its Buy Rating for AC Immune SA (ACIU)NASDAQ:ACIUAC Immune SA
12/11/202115:44Dow Jones NewsAC Immune Sees Positive Data in Trial for Alzheimer's Disease TreatmentNASDAQ:ACIUAC Immune SA
31/08/202116:55Dow Jones NewsAC Immune Shares Rally on Renewed Hope for Semorinemab in Alzheimer'sNASDAQ:ACIUAC Immune SA
31/08/202114:33Dow Jones NewsAC Immune: Semorinemab Meets Co-Primary Endpoint in Alzheimer's DiseaseNASDAQ:ACIUAC Immune SA
05/08/202123:16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACIUAC Immune SA
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACIU

La tua Cronologia

BIT
11COV
Bearer
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network